Skip to main content
Premium Trial:

Request an Annual Quote

XDx Gets FDA OK for Heart Transplant Molecular Dx Test

NEW YORK (GenomeWeb News) – XDx announced today that the US Food and Drug Administration has cleared for marketing the firm’s AlloMap multi-gene molecular expression test for heart transplant patients.
The non-invasive test is used in conjunction with standard clinical assessment to aid physicians in identifying heart transplant recipients with stable allograft function who have a low probability of moderate to severe acute cellular rejection at the time of testing. The AlloMap test includes 11 rejection biomarker genes and nine control genes, said XDx.
The Brisbane, Calif.-based firm noted that it is the first company to receive FDA clearance of an In Vitro Diagnostic Multivariate Index Assay for use in transplant management. It is the third such assay clearaed by the agency, following the February 2007 clearance of Agendia’s MammaPrint test and Pathwork Diagnostic’s Tissue of Origin test last month.
“This clearance and the FDA’s focus on this field underscore the growing importance of molecular diagnostics in the care of patients,” XDx President and CEO Pierre Cassigneul said in a statement.
XDx has been offering the test through its CLIA-certified lab since January 2005. The firm said the test was validated using data from nine heart transplant centers participating in the Cardiac Allograft Rejection Gene Expression Observational study.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.